Anandan Jeevanandham, Ottilingam Krishnarajasekhar R
Respiratory Medicine, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Cureus. 2024 Aug 7;16(8):e66412. doi: 10.7759/cureus.66412. eCollection 2024 Aug.
Granulomatosis with polyangiitis (GPA), formerly termed Wegener's granulomatosis, is an autoimmune disease marked by necrotizing granulomatous inflammation and vasculitis affecting small-sized vessels. It commonly impacts the renal and respiratory systems.
This retrospective case series sampling conducted in a tertiary care hospital between May 2023 and April 2024 examined six newly diagnosed GPA patients who were proteinase 3 cytoplasmic-antinuclear cytoplasmic antibody (PR3 c-ANCA) positive and had concurrent respiratory infections. None of them had any prior immunosuppressive conditions. The age range was 18-47 years with a mean of 35.0 (standard deviation: 11.83). All the patients had pneumonia (N=6, 100%). Out of all, five had bacterial pneumonia (N=5, 83.3%) and one had tuberculous pneumonia (N=1, 16.7%). A high level of PR3 c-ANCA (>150 RU/mL) was noted in four patients (N=4, 66.7%). Common symptoms included dry cough (N=5, 83.3%), loss of weight and appetite (N=2, 33.3%), and fever (N=2, 33.3%). Three patients had otitis media and/or nasal polyposis (N=3, 50%). Two patients (N=2, 33.3%) with life-threatening organ dysfunction were given concurrent antibiotics and steroids; the antibiotics were later modified based on culture and sensitivity results. One of these patients received antituberculosis therapy as (MTB) was detected after 27 days of incubation in mycobacterial growth indicator tube broth. The remaining four patients (N=4, 66.7%) received antibiotics initially for 5-7 days until clinical resolution of pneumonia. Ultimately, they all showed clinical and radiological resolution (N=6, 100%) within 3-6 months of treatment.
The patients exhibited constitutional symptoms such as fever and weight loss; lower airway disease symptoms including dry cough and hemoptysis; nasal and ear disease symptoms like epistaxis, ear pain, and ear discharge; and a renal disease symptom, hematuria. Computed tomography of the thorax revealed bilateral consolidations, most of which were cavitating. Bronchoalveolar lavage cultures grew , , , and MTB, whereas pus swab cultures from otitis media grew , and coagulase-negative staphylococci.
This study highlights the therapeutic challenges of GPA complicated by concurrent infections. Patients exhibited typical GPA signs, confirmed by PR3 c-ANCA levels. Concurrent infections require cautious antibiotic treatment before starting immunosuppressive therapy, except in life-threatening organ dysfunction. A unique case presented with both tuberculosis and GPA. Tailored treatment regimens combining antibiotics and immunosuppressives, including corticosteroids, methotrexate, and rituximab, resulted in clinical and radiological improvement in all the patients within 3-6 months. The addition of co-trimoxazole reduced the incidence of non-severe GPA relapses.
Tailored treatment plans addressing both infectious and autoimmune aspects are essential for optimal care in GPA complicated by concurrent infections. This study highlights the need for a multidisciplinary approach involving pulmonologist, rheumatologist, microbiologist, and pathologist in the diagnosis and treatment of GPA, emphasizing the importance of individualized treatment plans tailored to the specific clinical scenario.
肉芽肿性多血管炎(GPA),以前称为韦格纳肉芽肿,是一种自身免疫性疾病,其特征为坏死性肉芽肿性炎症和影响小血管的血管炎。它通常影响肾脏和呼吸系统。
本回顾性病例系列研究于2023年5月至2024年4月在一家三级护理医院进行,研究对象为6例新诊断的GPA患者,这些患者蛋白酶3胞质抗核胞质抗体(PR3 c-ANCA)呈阳性且并发呼吸道感染。他们均无既往免疫抑制病史。年龄范围为18 - 47岁,平均年龄为35.0岁(标准差:11.83)。所有患者均患有肺炎(n = 6,100%)。其中,5例为细菌性肺炎(n = 5,83.3%),1例为结核性肺炎(n = 1,16.7%)。4例患者(n = 4,66.7%)PR3 c-ANCA水平较高(>150 RU/mL)。常见症状包括干咳(n = 5,83.3%)、体重和食欲下降(n = 2,33.3%)以及发热(n = 2,33.3%)。3例患者患有中耳炎和/或鼻息肉(n = 3,50%)。2例有危及生命的器官功能障碍的患者同时接受了抗生素和类固醇治疗;抗生素后来根据培养和药敏结果进行了调整。其中1例患者在分枝杆菌生长指示管肉汤中培养27天后检测到结核分枝杆菌(MTB),随后接受了抗结核治疗。其余4例患者(n = 4,66.7%)最初接受了5 - 7天的抗生素治疗,直到肺炎临床症状缓解。最终,所有患者在治疗3 - 6个月内均实现了临床和影像学缓解(n = 6,100%)。
患者表现出诸如发热和体重减轻等全身症状;下呼吸道疾病症状,如干咳和咯血;鼻和耳部疾病症状,如鼻出血、耳痛和耳溢液;以及肾脏疾病症状血尿。胸部计算机断层扫描显示双侧实变,其中大部分有空洞形成。支气管肺泡灌洗培养物培养出肺炎克雷伯菌、金黄色葡萄球菌、铜绿假单胞菌和MTB,而中耳炎的脓性拭子培养物培养出肺炎链球菌和凝固酶阴性葡萄球菌。
本研究强调了并发感染的GPA的治疗挑战。患者表现出典型的GPA体征,PR3 c-ANCA水平证实了这一点。除了危及生命的器官功能障碍外,并发感染在开始免疫抑制治疗前需要谨慎使用抗生素。有一个独特的病例同时患有结核病和GPA。结合抗生素和免疫抑制剂(包括皮质类固醇、甲氨蝶呤和利妥昔单抗)的定制治疗方案使所有患者在3 - 6个月内实现了临床和影像学改善。添加复方新诺明降低了非严重GPA复发的发生率。
针对感染和自身免疫方面的定制治疗计划对于并发感染的GPA的最佳治疗至关重要。本研究强调了在GPA的诊断和治疗中需要呼吸科医生、风湿病学家、微生物学家和病理学家参与的多学科方法,强调了根据具体临床情况制定个性化治疗计划的重要性。